Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Bal, S; Malek, E; Kansagra, A; Usmani, SZ; Vij, R; Godby, KN; Cornell, RF; Kang, Y; Umyarova, E; Giri, S; Chhabra, S; Liedtke, M; Callander, NS; Hari, P; Kumar, S; Costa, LJ

Published Date

  • March 2022

Published In

Volume / Issue

  • 36 / 3

Start / End Page

  • 877 - 880

PubMed ID

  • 34802043

Electronic International Standard Serial Number (EISSN)

  • 1476-5551

Digital Object Identifier (DOI)

  • 10.1038/s41375-021-01471-3

Language

  • eng

Conference Location

  • England